March 20, 2018
Mylan launches Mitomycin, generic cancer drug version of BMS’s Mutamycin
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…
Pharmaceuticals, Biotechnology and Life Sciences
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…